Evidence map›Paper›PMID 37308774›Full record

ArticleJournal of nephrology2024

De novo HNF4A-associated atypical Fanconi renal tubulopathy syndrome.

Rebecca Hudson, Natasha Abeysekera, Penny Wolski, Cas Simons, Leo Francis, Elizabeth Farnsworth, Bruce Bennetts, Chirag Patel, Siebe Spijker, Andrew Mallett

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nephrology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rebecca HudsonDepartment of Renal Medicine, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Natasha AbeysekeraDepartment of Renal Medicine, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Penny WolskiDepartment of Diabetes and Endocrinology, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Cas SimonsCentre for Population Genomics, Garvan Institute of Medical Research, and University of New South Wales, Sydney, NSW, Australia.
Leo FrancisAnatomical Pathology, Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Elizabeth FarnsworthSydney Genome Diagnostics, Western Sydney Genetics Program, Children's Hospital Westmead, Westmead, NSW, Australia.
Bruce BennettsSydney Genome Diagnostics, Western Sydney Genetics Program, Children's Hospital Westmead, Westmead, NSW, Australia.
Chirag PatelGenetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Siebe SpijkerDepartment of Nephrology, Leiden University Medical Centre, Leiden, The Netherlands.
Andrew MallettDepartment of Renal Medicine, Townsville Hospital and Health Service, Townsville University Hospital, 100 Angus Smith Drive, Douglas, QLD, 4814, Australia. Andrew.mallett@health.qld.gov.au.ORCID 0000-0002-8752-2551

Funding

National Health and Medical Research Council GNT1098654
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Fanconi SyndromeHepatocyte Nuclear Factor 4HumansHepatocyte Nuclear Factor 4HNF4A protein, humanAtypical Fanconi Renal Tubulopathy SyndromeDe novo monogenic rare diseaseHNF4ATubulopathy

Identifiers

PMID37308774
PMCPMC10920409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.